Bank Of America Corp Verve Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 776,222 shares of VERV stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

776,222

Previous 473,016 64.1%

Holding current value

$3.53 Million

Previous $2.31 Million 62.74%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.4 - $7.86 $1.33 Million - $2.38 Million	303,206 Added 64.1%	776,222 $3.76 Million
Q2 2024 Aug 14, 2024	BUY	$4.76 - $12.79 $475,009 - $1.28 Million	99,792 Added 26.74%	473,016 $2.31 Million
Q1 2024 May 15, 2024	BUY	$10.81 - $17.96 $1.46 Million - $2.43 Million	135,351 Added 56.9%	373,224 $4.96 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $574,653 - $1.22 Million	65,006 Added 37.6%	237,873 $3.32 Million
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $2.83 Million - $4.22 Million	-211,839 Reduced 55.07%	172,867 $3.24 Million
Q1 2023 May 12, 2023	SELL	$14.3 - $24.01 $295,824 - $496,694	-20,687 Reduced 5.1%	384,706 $5.55 Million
Q4 2022 Feb 10, 2023	BUY	$17.85 - $40.7 $4.66 Million - $10.6 Million	261,198 Added 181.14%	405,393 $7.84 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $1.96 Million - $5.2 Million	125,406 Added 667.44%	144,195 $4.95 Million
Q2 2022 Aug 12, 2022	SELL	$11.14 - $23.17 $2.15 Million - $4.46 Million	-192,605 Reduced 91.11%	18,789 $287,000
Q1 2022 May 16, 2022	BUY	$20.92 - $39.36 $3.36 Million - $6.32 Million	160,544 Added 315.72%	211,394 $4.82 Million
Q4 2021 Feb 08, 2022	BUY	$31.94 - $54.82 $1.55 Million - $2.66 Million	48,594 Added 2153.99%	50,850 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $86,664 - $139,397	1,884 Added 506.45%	2,256 $106,000
Q2 2021 Sep 13, 2021	BUY	$31.92 - $60.25 $11,874 - $22,413	372 New	372 $22,000

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $273M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Verve Therapeutics, Inc. Transaction History